Berkeley Lovelace Jr.

KEY POINTS

• Moderna said its Covid-19 vaccine booster shot produced a “robust” antibody response against the highly contagious delta variant.
• In a phase two trial, Moderna is testing a 50-microgram dose of three vaccine booster candidates in previously vaccinated individuals.
• The data has been submitted to a peer-reviewed journal for publication, it said.

Moderna said its Covid-19 vaccine booster shot produced a “robust” antibody response against the highly contagious delta variant, according to details of a study released Thursday with the company’s second-quarter earnings report.

In a phase two trial, Moderna is testing a 50-microgram dose of three vaccine booster candidates in previously vaccinated individuals. The booster shots produced a promising immune response against three variants, including delta, with antibody levels approaching those seen in previously unvaccinated people who received two 100-microgram doses, the company said.

The data has been submitted to a peer-reviewed journal for publication, it said.

Continue Reading Here